FF
JNJ icon

Formulate Financial’s Johnson & Johnson JNJ Stock Holding History

Formulate Financial’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Buy
1,463
+598
+69% +$139K 0.39% 20
2026
Q1 		$211K Sell
865
-110
-11% -$25.6K 0.26% 26
2025
Q4 		$202K Buy
+975
New +$193K 0.24% 28

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Formulate Financial's JNJ Position: Q2 2026 in Review

Formulate Financial increased its Johnson & Johnson (JNJ) stake by 69% in Q2 2026, buying an estimated $139K and bringing the position to 1,463 shares worth $372K. The position accounts for 0.39% of the portfolio, ranked #20.

Formulate Financial first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Formulate Financial held 1,463 shares of Johnson & Johnson worth $372K as of Q2 2026.
  • Formulate Financial bought 598 Johnson & Johnson shares in Q2 2026, an estimated $139K.
  • Johnson & Johnson made up 0.39% of Formulate Financial's portfolio in Q2 2026, its #20 holding.
  • Formulate Financial first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Formulate Financial's 13F filing for Q2 2026, filed 31 Jul 2026.